Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
3.480
-0.270 (-7.20%)
At close: Nov 5, 2026, 4:00 PM EST
3.493
+0.013 (0.36%)
After-hours: Nov 5, 2026, 7:30 PM EST
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $96.94 million as of November 5, 2026. It is the 25,062nd most valuable company in the world and the 4,080th biggest in the United States. Its market cap has increased by 23.61% in one year.
Market Cap
96.94M
Enterprise Value
36.18M
1-Year Change
23.61%
Global Rank
Country Rank
#4,080 United States
Category
ChartMarket Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $96.94M, an increase of 45.79%. That is a compound annual growth rate of 7.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 96.94M | -21.83% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 112.03M |
| enGene Therapeutics | 109.24M |
| Anixa Biosciences | 108.81M |
| Milestone Pharmaceuticals | 108.36M |
| Immunic | 106.84M |
| Tenax Therapeutics | 105.97M |
| PDS Biotechnology | 105.81M |
| PMV Pharmaceuticals | 105.72M |